Cargando…
Excess hepsin proteolytic activity limits oncogenic signaling and induces ER stress and autophagy in prostate cancer cells
The serine protease hepsin is frequently overexpressed in human prostate cancer (PCa) and is associated with matrix degradation and PCa progression in mice. Curiously, low expression of hepsin is associated with poor survival in different cancer types, and transgenic overexpression of hepsin leads t...
Autores principales: | Willbold, Ramona, Wirth, Katharina, Martini, Thomas, Sültmann, Holger, Bolenz, Christian, Wittig, Rainer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6689070/ https://www.ncbi.nlm.nih.gov/pubmed/31399560 http://dx.doi.org/10.1038/s41419-019-1830-8 |
Ejemplares similares
-
Correction: Excess hepsin proteolytic activity limits oncogenic signaling and induces ER stress and autophagy in prostate cancer cells
por: Willbold, Ramona, et al.
Publicado: (2020) -
Venetoclax is a potent hepsin inhibitor that reduces the metastatic and prothrombotic phenotypes of hepsin-expressing colorectal cancer cells
por: Rodenas, Maria Carmen, et al.
Publicado: (2023) -
Clinical Significance of Hepsin and Underlying Signaling Pathways in Prostate Cancer
por: Lu, Lucy, et al.
Publicado: (2022) -
HEV-ORF3 Encoding Phosphoprotein Interacts With Hepsin
por: Wang, Chunyan, et al.
Publicado: (2014) -
Design of drug-like hepsin inhibitors against prostate cancer and kidney stones
por: Blay, Vincent, et al.
Publicado: (2020)